The contribution of imprinted genes to neurodevelopmental and neuropsychiatric disorders (2022)
Attributed to:
De-risking PWS drug development through preclinical screening
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41398-022-01972-4
PubMed Identifier: 35597773
Publication URI: http://europepmc.org/abstract/MED/35597773
Type: Journal Article/Review
Parent Publication: Translational Psychiatry
Issue: 1
ISSN: 2158-3188